Skip to content

Assessing determinants of breast cancer patients in Indonesia for delayed diagnosis, treatment, risks of relapse, and survival

Assessing demographic, social, clinical, and pathological determinants of breast cancer patients for delayed diagnosis, treatment, risks of relapse, and survival

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN13788093
Enrollment
2000
Registered
2020-10-02
Start date
2018-04-06
Completion date
Unknown
Last updated
2022-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sociodemographic and clinicopathological determinants in breast cancer diagnosis and prognosis Cancer Malignant neoplasm of breast

Interventions

In this study, sociodemographic and clinicopathological variables will be collected and breast cancer patients will be followed-up for the locoregional recurrence, progression into distant metastasis,

Sponsors

Universitas Gadjah Mada
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Confirmed breast cancer according to the pathology report 2. Participants are able to provide written informed consent (over 18 years old) 3. No emergency procedure is required during the first presentation

Exclusion criteria

Exclusion criteria: 1. Vulnerable breast cancer patients

Design outcomes

Primary

MeasureTime frame
Overall survival at the end of the study measured using patient records

Secondary

MeasureTime frame
1. Sociodemographic backgrounds, occupation, income, general understanding of cancer, and hormonal factors such as menarche, menopause, BMI, contraception, number of children, breastfeeding practice, and usage of hormonal replacement therapy measured using a novel questionnaire at baseline 2. Cancer progression into distant metastasis, defined as presence of cancer spread to the lung, bone, liver, and brain indicating with clinical manifestations and were confirmed with imaging/pathology examination and/or radiologic changes confirmed with computed tomography imaging with contrast or whole-body bone scan every 6 months after baseline 3. Other clinical findings revealed by thorough clinical examination and imaging conducted at routine follow up visits retrieved from patient records

Countries

Indonesia

Contacts

Public ContactSumadi Lukman Anwar
sl.anwar@ugm.ac.id+62-274-581333

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026